Specialty Pharmacy

Sep 27, 2010
The market for hypertension drugs will drop by $3 billion by the end of...
BURLINGTON, Mass. The market for hypertension drugs will drop by $3...
more
Sep 27, 2010
Pfizer has halted a late-stage trial of a drug therapy in men with...
NEW YORK Pfizer has halted a late-stage trial of a drug therapy in men...
more
Sep 27, 2010
The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s...
NEW YORK The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb...
more
Sep 26, 2010
An investigational drug made by Johnson & Johnson for treating pain...
RARITAN, N.J. An investigational drug made by Johnson & Johnson for...
more
Sep 22, 2010
The Food and Drug Administration has accepted AstraZeneca’s regulatory...
LONDON The Food and Drug Administration has accepted AstraZeneca’s...
more
Sep 21, 2010
Swiss drug maker Novartis said its investigational drug is the first to...
EAST HANOVER, N.J. Swiss drug maker Novartis said its investigational drug...
more
Sep 20, 2010
A Food and Drug Administration advisory committee has recommended approval...
RIDGEFIELD, Conn. A Food and Drug Administration advisory committee has...
more

EXCLUSIVE REPORT

RxImpact 2014
Timed with NACDS RxImpact Day on Capitol Hill, DSN looks at how community pharmacy fills gaps in access and affordability for patients and payers. Click here to download the exclusive report.

SPECIALTY PHARMACY ROUNDTABLE

The Drug Store News Group/Specialty Pharmacy magazine hosted an exclusive executive roundtable discussion of leading specialty pharmacy providers. Click here for a PDF of their discussion, including channel management strategies, accountable care organizations and the importance of technology.

 

SPECIALTY PHARMACY Q&A

It has been estimated that specialty accounts for about 20% of the total drug...

SPECIAL REPORT

Can one of the nation’s premier specialty pharmacies maintain its focus on each...